European Archives - Page 63 of 1344 - European Medical Journal

ESMO 2025: Expanding treatment options in mHSPC

Join leading prostate cancer experts, Prof. Kim Chi (Canada), Prof. Nick James (UK), and Prof. Bertrand Tombal at ESMO 2025 in Berlin to…

finding Spinal Tumour

MRI Radiomics Model Enhances Prognostic Prediction in Spinal Tumours

MRI-based nested habitat radiomics improves prediction of progression-free survival in spinal tumours, highlighting aggressive tumour subregions.

brain damage in rugby players

Study Reveals Brain Damage in Rugby Players

Researchers find early signs of brain damage in rugby players through advanced imaging and biomarker analysis.

50 states of the US

Novo and Lilly agree to cut obesity drug costs in US

Novo Nordisk and Eli Lilly have made deals with President Trump to make their obesity medicines cheaper and easier to obtain in the US.

wellbeing in vitiligo

Physical Activity and Psychological Wellbeing in Vitiligo Study

The relationship between physical activity and psychological wellbeing in vitiligo has gained attention in recent years.

Myelofibrosis Treatment in Patients with Anaemia: Expert Discussion

This podcast episode focuses on two abstracts presented at EHA 2025 on momelotinib for the treatment of myelofibrosis in patients…

Airplane on blue background

Dedicated EU–US air route for life sciences launched

Frontier Scientific launches EU–US air corridor for life sciences, ensuring faster, safer delivery of temperature-sensitive medicines.

heart failure

Stem Cells Prevent Heart Failure After Heart Attack

Researchers find stem cells reduce heart failure risk after myocardial infarction, offering promising results for cardiac recovery.

bladder cancer

New Protein Biomarker Serves as a Diagnostic Tool for Bladder Cancer

A new study finds the DR-70 protein may help detect bladder cancer early and assess disease severity, offering a promising tool for patient care.

α1-antitrypsin deficiency

Lung Disease in Never-Smokers with Severe α1-Antitrypsin Deficiency

Never-smokers with severe α1-antitrypsin deficiency can still develop lung disease, including emphysema, bronchiectasis, and airflow obstruction.